Junichi Hisatake

970 total citations
21 papers, 784 citations indexed

About

Junichi Hisatake is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, Junichi Hisatake has authored 21 papers receiving a total of 784 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Molecular Biology and 8 papers in Hematology. Recurrent topics in Junichi Hisatake's work include Retinoids in leukemia and cellular processes (6 papers), Acute Myeloid Leukemia Research (4 papers) and Estrogen and related hormone effects (4 papers). Junichi Hisatake is often cited by papers focused on Retinoids in leukemia and cellular processes (6 papers), Acute Myeloid Leukemia Research (4 papers) and Estrogen and related hormone effects (4 papers). Junichi Hisatake collaborates with scholars based in Japan, United States and Greece. Junichi Hisatake's co-authors include H. Phillip Koeffler, Shigeru Tomoyasu, James O’Kelly, Takayuki Ikezoe, June E. Bishop, Anthony W. Norman, Milan R. Uskoković, Sylvia A. Holden, Michael Carey and Tetsuya Kubota and has published in prestigious journals such as Journal of Clinical Investigation, Blood and British Journal of Haematology.

In The Last Decade

Junichi Hisatake

21 papers receiving 775 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junichi Hisatake Japan 11 424 234 149 124 119 21 784
Michi Tanaka Japan 14 232 0.5× 124 0.5× 94 0.6× 112 0.9× 107 0.9× 25 959
Azhar R. Hussain Saudi Arabia 18 522 1.2× 221 0.9× 269 1.8× 48 0.4× 280 2.4× 37 989
Ece Konaç Türkiye 19 468 1.1× 88 0.4× 280 1.9× 119 1.0× 145 1.2× 59 941
Maokaı̈ Gong United States 13 349 0.8× 91 0.4× 53 0.4× 45 0.4× 262 2.2× 15 915
Yasutoshi Muto Japan 9 283 0.7× 108 0.5× 118 0.8× 64 0.5× 108 0.9× 14 818
Billy R. Ballard United States 15 387 0.9× 179 0.8× 168 1.1× 68 0.5× 183 1.5× 37 908
Youngmin A. Lee United States 14 433 1.0× 75 0.3× 158 1.1× 64 0.5× 122 1.0× 19 1.8k
Mark Wade United States 13 314 0.7× 54 0.2× 80 0.5× 58 0.5× 150 1.3× 35 632
Kurumi Sasatomi Japan 14 275 0.6× 42 0.2× 159 1.1× 151 1.2× 184 1.5× 17 1.0k
Megan Garrity-Park United States 13 474 1.1× 141 0.6× 144 1.0× 164 1.3× 198 1.7× 19 968

Countries citing papers authored by Junichi Hisatake

Since Specialization
Citations

This map shows the geographic impact of Junichi Hisatake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junichi Hisatake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junichi Hisatake more than expected).

Fields of papers citing papers by Junichi Hisatake

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junichi Hisatake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junichi Hisatake. The network helps show where Junichi Hisatake may publish in the future.

Co-authorship network of co-authors of Junichi Hisatake

This figure shows the co-authorship network connecting the top 25 collaborators of Junichi Hisatake. A scholar is included among the top collaborators of Junichi Hisatake based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junichi Hisatake. Junichi Hisatake is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hisatake, Junichi, et al.. (2008). [Hypercalcemia associated with all-trans retinoic acid therapy for microgranular type acute promyelocytic leukemia].. PubMed. 49(6). 408–12. 2 indexed citations
3.
Matsunawa, Manabu, et al.. (2003). [Hepatitis-associated aplastic anemia preceded by a hemophagocytic syndrome-like state].. PubMed. 44(10). 1010–4. 1 indexed citations
4.
Nakamaki, Tsuyoshi, Junichi Hisatake, Akihiro Yokoyama, et al.. (2003). Elevated levels of cyclin A1 and A (A2) mRNA in acute myeloid leukaemia are associated with increased survival. British Journal of Haematology. 123(1). 72–80. 10 indexed citations
5.
O’Kelly, James, et al.. (2002). Normal myelopoiesis but abnormal T lymphocyte responses in vitamin D receptor knockout mice. Journal of Clinical Investigation. 109(8). 1091–1099. 88 indexed citations
6.
O’Kelly, James, et al.. (2002). Normal myelopoiesis but abnormal T lymphocyte responses in vitamin D receptor knockout mice. Journal of Clinical Investigation. 109(8). 1091–1099. 122 indexed citations
7.
O’Kelly, James, et al.. (2002). Normal myelopoiesis but abnormal T lymphocyte responses in vitamin D receptor knockout mice. Journal of Clinical Investigation. 109(8). 1091–1099. 10 indexed citations
8.
Hisatake, Junichi, et al.. (2002). [Primary subcutaneous mantle cell lymphoma treated successfully with THP-COP therapy].. PubMed. 43(5). 384–8. 2 indexed citations
9.
Hisatake, Junichi, James O’Kelly, Milan R. Uskoković, Shigeru Tomoyasu, & H. Phillip Koeffler. (2001). Novel vitamin D3 analog, 21-(3-methyl-3-hydroxy-butyl)-19-nor D3, that modulates cell growth, differentiation, apoptosis, cell cycle, and induction of PTEN in leukemic cells. Blood. 97(8). 2427–2433. 66 indexed citations
10.
Shiohara, Masaaki, Milan R. Uskoković, Junichi Hisatake, et al.. (2001). 24-Oxo metabolites of vitamin D3 analogues: disassociation of their prominent antileukemic effects from their lack of calcium modulation.. PubMed. 61(8). 3361–8. 20 indexed citations
11.
Ikezoe, Takayuki, Miller Cw, Seiji Kawano, et al.. (2001). Mutational analysis of the peroxisome proliferator-activated receptor gamma gene in human malignancies.. PubMed. 61(13). 5307–10. 118 indexed citations
12.
Kubota, Tetsuya, Junichi Hisatake, Jonathan Said, et al.. (2000). PC-SPES: A unique inhibitor of proliferation of prostate cancer cells in vitro and in vivo. The Prostate. 42(3). 163–171. 64 indexed citations
13.
Ikezoe, Takayuki, Eric S. Daar, Junichi Hisatake, Hirokuni Taguchi, & H. Phillip Koeffler. (2000). HIV-1 protease inhibitors decrease proliferation and induce differentiation of human myelocytic leukemia cells. Blood. 96(10). 3553–3559. 10 indexed citations
14.
Kubota, Tetsuya, Junichi Hisatake, Jonathan Said, et al.. (2000). PC-SPES: A unique inhibitor of proliferation of prostate cancer cells in vitro and in vivo. The Prostate. 42(3). 163–163. 6 indexed citations
15.
Hisatake, Junichi, Takayuki Ikezoe, Michael Carey, et al.. (2000). Down-Regulation of prostate-specific antigen expression by ligands for peroxisome proliferator-activated receptor gamma in human prostate cancer.. PubMed. 60(19). 5494–8. 132 indexed citations
16.
Ikezoe, Takayuki, Eric S. Daar, Junichi Hisatake, Hirokuni Taguchi, & H. Phillip Koeffler. (2000). HIV-1 protease inhibitors decrease proliferation and induce differentiation of human myelocytic leukemia cells. Blood. 96(10). 3553–3559. 41 indexed citations
17.
Koike, Makoto, Junichi Hisatake, Shigeru Tomoyasu, et al.. (1997). [Extramedullary plasmacytoma with multiple metastasis following a maxillary plasmacytoma].. PubMed. 38(4). 336–41. 3 indexed citations
18.
Hisatake, Junichi, Michiaki Koike, Isao Matsuda, et al.. (1996). Nasopharyngeal natural killer cell lymphoma with pericardial infiltration.. Japanese Journal of Clinical Immunology. 19(2). 145–149. 2 indexed citations
19.
Nakamaki, Tsuyoshi, Atsushi Yokoyama, Junichi Hisatake, et al.. (1994). Effect of cytokines on the proliferation and differentiation of acute promyelocytic leukemia cells: possible relationship to the development of "retinoic acid syndrome".. PubMed. 14(3A). 817–23. 13 indexed citations
20.
Hisatake, Junichi, et al.. (1994). [Autoimmune hemolytic anemia associated with multicentric Castleman's disease with a 28-year history].. PubMed. 35(8). 768–73. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michi Tanaka Breakdown of academic impact, for papers by Azhar R. Hussain Breakdown of academic impact, for papers by Ece Konaç Breakdown of academic impact, for papers by Maokaı̈ Gong Breakdown of academic impact, for papers by Yasutoshi Muto Breakdown of academic impact, for papers by Billy R. Ballard Breakdown of academic impact, for papers by Youngmin A. Lee Breakdown of academic impact, for papers by Mark Wade Breakdown of academic impact, for papers by Kurumi Sasatomi Breakdown of academic impact, for papers by Megan Garrity-Park
Rankless by CCL
2026